In cartilage collagen type XI exists as heterotrimeric molecules composed of ol(XI), a2(XI) and a3(XI) subunits. Messenger RNAs for some of the a chains of collagen type XI have also been found in non-chondrogenic tissues but the chain composition of the molecule in these sites is not known. Some nonchondrogenic tissues also contain heterotrimers containing collagen a2(V) and al(XI) chains. We have explored the possibility that collagen type XI could exist in differing trimeric forms in non-chondrogenic tissues and aimed to predict the subunit composition of this collagen in those tissues. The distribution and relative levels of expression of collagen al(XI), oc2(XI) and a3(XI)/al(II) mRNAs in different human fetal tissues were studied. Expression of mRNAs for all three genes of collagen
INTRODUCTION
The structural integrity and functional properties of the extracellular matrix (ECM) of different tissues is influenced by the presence of characteristic combinations and amounts of various collagen types and other matrix components which are expressed in a developmental and tissue-specific manner [1] . Collagens form supramolecular structures in the ECM such as fibrils, filaments or networks [2] and the 19 genetically distinct types can be sub-classified into various families, the largest of which are the fibril-forming collagens, i.e. types I, II, III, V and XI [3] .
The fibrils in the ECM of bones, skin, tendons and ligaments are predominantly heterotypic, containing mainly collagen type I with collagen types III and V as quantitatively minor components [2] . Heterotypic fibrils in cartilage contain collagen type II as the quantitatively major component, with collagen type XI within the centre and collagen type IX decorating the outer surface [2] . It has been proposed that collagen types V and XI play a role in regulating fibrillogenesis and modulating fibril diameter [2, 4] . This hypothesis is supported by recent findings that absence of collagen al(XI) chains results in abnormally thickened cartilage fibrils in the cho mouse mutant [5, 6] and a consequence of targeted mutation of the collagen a2(V) gene in mice is widened, disorganized fibrils [7] .
In cartilage, collagen type XI is a heterotrimer composed of al(XI), a2(XI) and a3(XI) subunits [8] . The collagen al(XI) and a2(XI) chains are genetically distinct products of separate genes type XI is not restricted to cartilage but is widespread. However, in some non-chondrogenic tissues, the mRNAs for all three a chains of collagen type XI were not co-expressed, but collagen al(XI) and a2(XI) mRNAs were found either singly or without collagen a3(XI) transcripts. Collagen type XI may therefore exist as homotrimers and/or heterotrimers composed of two collagen ac(XI) chains in some tissues. The distribution of mRNAs for collagen a2(V) and al(I) were also studied. Co-expression of collagen type XI, a2(V) and a l(I) mRNAs was found for many tissues. These findings have implications for the possibility of additional chain associations for collagen types XI and V in cross-type heterotrimers within heterotypic fibrils. [9, 10] while the collagen a3(XI) chain is an over-glycosylated variant of collagen c (II) [11] . Although cartilage is the main site of expression of collagen type XI, recent findings show a more widespread tissue distribution. Collagen a l(XI) mRNAs have been reported in a number of human cell-lines and nonchondrogenic chicken tissues [9, [12] [13] [14] . Collagen a2(XI) transcripts have been detected in a variety ofhuman non-chondrogenic embryonic tissues [15] . The presence of mRNA implies, but does not prove, that the protein is also synthesized. Using immunological and protein extraction methods, collagen aI1(XI) chains have been found in heterotrimers with collagen a2(V) in bovine bone, vitreous humour and human A204 rhabdomyosarcoma cells [16] [17] [18] We show that expression of all three collagen type XI genes is not restricted to cartilage but is widespread. However, in some non-chondrogenic tissues, mRNAs for the three a chains of collagen type XI are not co-expressed. To investigate if intertype associations between collagen c2(V) and other collagen a(XI) chains were possible, the distribution of collagen a2(V) mRNAs was also studied. In general, the mRNAs for collagen type XI and collagen a2(V) are co-expressed in non-chondrogenic tissues.
EXPERIMENTAL Human fetal material
Human fetal tissues were obtained from therapeutic terminations of pregnancy with the approval of the Ethics Committee of the Medical Faculty of Hong Kong University. The gestation age of the fetuses was determined from the crown-rump length [19] and the estimated last menstrual period.
Plasmid probes
Recombinant plasmids used to produce antisense riboprobes for RNase protection assays were as described below. Nucleotide fragments of shorter than expected size obtained for collagen al(XI) and a2(XI) mRNAs respectively, were products of RNase overdigestion, which either disappeared or were significantly reduced in intensity when less enzyme was used. 
RNA Isolation
Total RNA was prepared from human fetal tissues and primary chondrocyte cultures by the LiCl/urea differential precipitation method [20] . Primary chondrocyte cultures were prepared from 17-week fetal cartilage by digesting minced tissue with collagenase (1.5 mg/ml) for 16 h in Dulbecco's modified Eagle's medium (DMEM), 10% (v/v) fetal calf serum (FCS) containing antibiotics [1 % (w/v) each of penicillin, streptomycin and nystatin]. Dispersed chondrocytes were grown in suspension culture in bacteriological dishes in DMEM with 10 % (v/v) FCS, ascorbic acid (100 ,ug/ml), 8-aminopropiononitrile fumarate (2.5 mM) and antibiotics. Total RNA was extracted from chondrocytes after 2 to 3 days in culture.
RNA was also extracted from the following tissues from five human fetuses at 15-, 16-, 17-, 19-and 24-week gestation: (a) 15-week, cartilage, kidney, lung, liver, skeletal muscle, calvaria, frontal lobe of brain, and parietal occipital lobe of brain; (b) 16-week, skin and bone; (c) 17-week, chondrocytes, heart, whole brain, kidney, gut, liver, tendon, skeletal muscle, lung, and spleen; (d) 19-week, cartilage; and (e) 24-week, brain dissected into parietal lobe, frontal lobe, parietal occipital lobe, temporal lobe, meninges, thalamus and caudate nucleus.
RNase protection assays Syntheses of antisense riboprobes from plasmids and RNase protection assays were carried out as previously described [21] . T7 or T3 RNA polymerase (New England Biolabs) and [a-32P]UTP (800 Ci/mmol, Amersham International) was used to generate riboprobes for RNase protection assays. Total RNA (20 or 40,tg) were used in RNase protection assays, the RNaseprotected fragments separated on 6 % (w/v) polyacrylamide/8 M urea sequencing gels and the protected fragments were detected by autoradiography.
To determine the relative levels of the three collagen type XI mRNAs within a sample, equal amounts (5 x 105 c.p.m. each) of [c_-32P]UTP-labelled specific riboprobes for either collagen a l(XI) plus a3(XI) or acl(XI) plus cz2(XI) were included in the same protection assay. For each set of determinations, autoradiography was for identical periods. An LKB 2202 UltroScan Laser Densitometer was used for densitometry on autoradiograms and the areas under the absorbance peaks corresponding to the protected fragments were integrated. Since amounts of riboprobe were present in excess, the intensities of the protected RNA fragments, as determined by densitometry, were assumed to be directly proportional to their relative levels after making a correction for the number of protected labelled U's for each probe. Relative amounts of collagen al(XI), ac2(XI) and a3(XI) mRNAs were calculated as follows: amount of collagen a(XI) mRNA = I/N; where I = intensity of the protected RNA fragment and N = number of U's in the protected fragment.
Since collagen al(XI) riboprobe was common in each double riboprobe assay, levels of collagen a2(XI) and a3(XI) mRNAs were calculated relative to collagen acl(XI) mRNA and fractional amounts were multiplied by a factor for clarity of representation. For example, the calculated transcript ratios for collagen al(XI):at2(XI) and collagen cal(XI): 3(XI) in kidney were 1.5:1 and 1.5:10 respectively, which is equivalent to mRNA proportions for collagen al(XI): a2(XI): cx3(XI) of 3:2:20.
RESULTS AND (Figure 1 ). In contrast, coexpression of collagen a2(XI) and a3(XI)/al(II) transcripts in the epidermis of developing fetal skin and intestine detected by in situ hybridization and RNase protection assays has been reported [15] . Absence of expression in the fetal skin and gut samples studied here cannot be accounted for by RNA degradation since collagen a2(V) and al(I) transcripts were clearly present in the same mRNA preparation (Figure 1 ). Transcripts for collagen a3(XI)/cl(II) in the frontal and parietal occipital lobes of the brain were present at 15 weeks gestation but absent in these regions at week 24 . These findings also differ from the Co-expression of collagen type Xl, o2(V) and oel(l) mRNAs Collagen a2(V) mRNA was found in all non-chondrogenic tissues studied but expression was transient in parts of the brain, being absent in the parietal occipital lobe at 24-week but present at 15-week gestation (Figures 1 and 3 ). Collagen a2(V) mRNAs were found with one or more of the collagen type XI mRNAs with the exception of 17-week spleen and 16-week skin in which collagen cc2(V) mRNA was expressed in the absence of collagen c(XI) mRNAs (Figures 1 and 3 ; Table 1 ). Collagen a2(V), a l(I), and the three a(XI) mRNAs were co-expressed in many nonchondrogenic tissues such as 15-week calvaria, kidney, muscle, and parts of the brain, 16-week bone, 17-week tendon and lung, 24-week meninges and caudate nucleus (Figures 1 and 2 and Table 1 ). Co-expression of all these mRNAs was transient in some tissues such as lung, kidney, muscle and brain (Table 1) . RNase protection assays on RNA from 24-week brain. Total RNA (40 ,g) was assayed for each track. Yeast tRNA (20 ,ug) was included as the no RNA control (N). Sizes of specific protected fragments in nt (arrows) for collagen al (XI) and cx2(XI) were as for Figure 1 . For collagen a3(XI)/axl (11), a riboprobe for the 3'-untranslated region of COL2A1 mRNA was used instead, yielding a protected fragment of 390 nt. Abbreviations: P, parietal lobe; F, frontal lobe; P0, parietal occipital lobe; T, temporal lobe; Me, meninges; Th, thalamus; CN, caudate nucleus; M, 32P-labelled Hpall-digested pGEM2 markers.
recent report where transcripts were detected only in meninges [15] . Transient expression of collagen a3(XI)/al(II) mRNAs in the developing skin of chick [24] and mouse [22] and in the brain of human and mouse has been reported [22, 23, 25] . Although the fetal stages of the individual tissues studied by Sandberg et al. [15] were not specified, our different observations could reflect transient expression of collagen type XI during development. Other examples of possible developmentally transient expression of collagen a(XI) mRNAs was found for kidney, lung and skeletal muscle. Transcripts for collagen a2(XI) were absent in 15-week but present in 17-week lung; collagen a I(XI) transcripts were absent in 17-week but present in 15-week kidney (Figures 1  and 2 RNase protection analyses using two different riboprobes within a single assay were carried out using cartilage mRNAs (see the Experimental section) and the relative amounts of collagen ac(XI), a2(XI) and a3(XI) mRNAs found to be 1: 1:4, respectively ( Table 2 ). The 1:1 ratio of collagen a l(XI) to a2(XI) mRNAs found, corresponds to that expected for a heterotrimeric collagen type XI molecule containing collagen al(XI), a2(XI) and a3(XI) chains [8] . The fourfold higher level for collagen a3(XI)/al(II) probably reflects the added presence of collagen type II.
Relative amounts of collagen cc1(Xl), a2(Xl) and a3(Xl) mRNAs in non-chondrogenic tissues Distribution of collagen type XI and collagen m2(V) mRNAs: implications for homotrimeric, heterotrimeric and heterotypic collagen molecules Our detailed study of the distribution and levels of expression of mRNAs of collagen type-XI and collagen a2(V) mRNAs in human fetuses show that these transcripts are widely but not necessarily co-expressed. The varied combinations of co-expression of collagen a(XI) and collagen a2(V) mRNAs and the marked differences in relative levels of the different transcripts, raise questions whether homotrimeric molecules composed of either collagen al(XI) or a2(XI); or heterotrimeric molecules composed of collagen al(XI) and a2(XI) alone; or additional kinds of heterotypic collagen a2(V)/a(XI) molecules exist in the fibrils of non-chondrogenic tissues. It is not known if the translational efficiencies for all three collagen a(XI) mRNAs were equal in these tissues. The relative rates of assembly of homotrimers and heterotrimers are also unknown. But it would be reasonable to suggest that where one of the transcripts was vastly in excess of the other two, homotrimeric molecules as well as heterotrimers could also be present. Direct demonstration that these varied trimeric forms of collagen type XI exist in the ECM awaits development of appropriate tools for detecting and distinguishing between the individual collagen a(XI) chains. Once such tools are available, choice of target tissues for study can be made on the basis of the findings described here. Since fibrils can contain collagen types I, III and V [2,27], and coexpression of collagen al(I), a2(V) and a(XI) mRNAs was found, it would also be important to determine if different trimeric forms of collagen type XI and heterotypic type XI-V collagen are present within fibrils containing collagen type I.
Questions also arise whether collagen a(XI) and a2(V) chains may be functionally interchangeable in some non-chondrogenic tissues, in which case loss of one collagen a(XI) chain may be compensated for by another, at least partially. Mutations in the human COLIIA2 gene have recently been shown to cause several autosomal dominant and recessive osteochondrodysplasias [28] . The chondrodysplasia in the cho mouse has also been shown to be caused by a mutation in Collla-i [6] . It is interesting that although collagen type XI is expressed in many non-chondrogenic tissues, apart from the skeletal abnormalities, other defects have not been described for these chondrodysplasias. However, compensation may be partial or possible only in particular tissues, since mutation of the collagen a2(V) gene causes abnormal fibril assembly in skin and cornea [7] . In this context it is interesting that we could not detect collagen type-XI transcripts in skin. To address these questions it would be important to determine whether changes in the trimeric composition of collagen type XI and V molecules are associated with disorders caused by mutations in the genes for these collagens.
